2Y3L
 
 | Structure of segment MVGGVVIA from the amyloid-beta peptide (Ab, residues 35-42), alternate polymorph 2 | Descriptor: | AMYLOID BETA A4 PROTEIN | Authors: | Colletier, J.P, Laganowsky, A, Sawaya, M.R, Eisenberg, D. | Deposit date: | 2010-12-21 | Release date: | 2011-11-02 | Last modified: | 2024-05-08 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | Molecular Basis for Amyloid-{Beta} Polymorphism. Proc.Natl.Acad.Sci.USA, 108, 2011
|
|
2Y3J
 
 | Structure of segment AIIGLM from the amyloid-beta peptide (Ab, residues 30-35) | Descriptor: | AMYLOID BETA A4 PROTEIN | Authors: | Colletier, J.P, Laganowsky, A, Sawaya, M.R, Eisenberg, D. | Deposit date: | 2010-12-21 | Release date: | 2011-11-02 | Last modified: | 2024-05-08 | Method: | X-RAY DIFFRACTION (1.99 Å) | Cite: | Molecular Basis for Amyloid-{Beta} Polymorphism. Proc.Natl.Acad.Sci.USA, 108, 2011
|
|
2Y3K
 
 | Structure of segment MVGGVVIA from the amyloid-beta peptide (Ab, residues 35-42), alternate polymorph 1 | Descriptor: | AMYLOID BETA A4 PROTEIN | Authors: | Colletier, J.P, Laganowsky, A, Sawaya, M.R, Eisenberg, D. | Deposit date: | 2010-12-21 | Release date: | 2011-11-02 | Last modified: | 2024-05-08 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Molecular Basis for Amyloid-{Beta} Polymorphism. Proc.Natl.Acad.Sci.USA, 108, 2011
|
|
2Y2A
 
 | Structure of segment KLVFFA from the amyloid-beta peptide (Ab, residues 16-21), alternate polymorph I | Descriptor: | ACETATE ION, AMYLOID BETA A4 PROTEIN | Authors: | Colletier, J, Laganowsky, A, Sawaya, M.R, Eisenberg, D. | Deposit date: | 2010-12-14 | Release date: | 2011-10-26 | Last modified: | 2024-05-08 | Method: | X-RAY DIFFRACTION (1.91 Å) | Cite: | Molecular Basis for Amyloid-{Beta} Polymorphism. Proc.Natl.Acad.Sci.USA, 108, 2011
|
|
6J60
 
 | hnRNP A1 reversible amyloid core GFGGNDNFG (residues 209-217) | Descriptor: | 9-mer peptide (GFGGNDNFG) from Heterogeneous nuclear ribonucleoprotein A1 | Authors: | Luo, F, Zhou, H, Gui, X, Li, D, Li, X, Liu, C. | Deposit date: | 2019-01-12 | Release date: | 2019-04-03 | Last modified: | 2024-03-27 | Method: | ELECTRON CRYSTALLOGRAPHY (0.96 Å) | Cite: | Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly. Nat Commun, 10, 2019
|
|
4ZAK
 
 | Crystal structure of the mCD1d/DB06-1/iNKTCR ternary complex | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Antigen-presenting glycoprotein CD1d1, ... | Authors: | Zajonc, D.M, Birkholz, A.M. | Deposit date: | 2015-04-13 | Release date: | 2015-07-01 | Last modified: | 2024-10-09 | Method: | X-RAY DIFFRACTION (2.824 Å) | Cite: | A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-gamma Production. J Immunol., 195, 2015
|
|
8PWW
 
 | PfRH5 bound to monoclonal antibody MAD8-151 | Descriptor: | 1,2-ETHANEDIOL, DI(HYDROXYETHYL)ETHER, GLYCEROL, ... | Authors: | Farrell, B, Higgins, M.K. | Deposit date: | 2023-07-21 | Release date: | 2024-06-05 | Last modified: | 2024-12-18 | Method: | X-RAY DIFFRACTION (1.945 Å) | Cite: | Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell, 187, 2024
|
|
8PWU
 
 | PfRH5 bound to monoclonal antibody MAD10-255 | Descriptor: | Reticulocyte-binding protein homolog 5, monoclonal antibody MAD10-255 | Authors: | Farrell, B, Higgins, M.K. | Deposit date: | 2023-07-21 | Release date: | 2024-06-05 | Last modified: | 2024-12-18 | Method: | X-RAY DIFFRACTION (3.148 Å) | Cite: | Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell, 187, 2024
|
|
8Q5D
 
 | PfRH5 bound to monoclonal antibody MAD10-466 | Descriptor: | Monoclonal antibody MAD10-466 heavy chain, Monoclonal antibody MAD10-466 light chain, Reticulocyte-binding protein homolog 5 | Authors: | Farrell, B, Higgins, M.K. | Deposit date: | 2023-08-08 | Release date: | 2024-06-05 | Last modified: | 2024-12-18 | Method: | X-RAY DIFFRACTION (3.2 Å) | Cite: | Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell, 187, 2024
|
|
8PWV
 
 | PfRH5 bound to monoclonal antibody MAD8-502 | Descriptor: | Reticulocyte-binding protein homolog 5, monoclonal antibody MAD8-502 | Authors: | Farrell, B, Higgins, M.K. | Deposit date: | 2023-07-21 | Release date: | 2024-06-05 | Last modified: | 2024-12-18 | Method: | X-RAY DIFFRACTION (2.07 Å) | Cite: | Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell, 187, 2024
|
|
8PWX
 
 | PfRH5 bound to monoclonal antibody R5.008 | Descriptor: | GLYCEROL, Reticulocyte-binding protein homolog 5, scFv fragment for antibody R5.008 | Authors: | Farrell, B, Higgins, M.K. | Deposit date: | 2023-07-21 | Release date: | 2024-06-05 | Last modified: | 2024-12-18 | Method: | X-RAY DIFFRACTION (3.2 Å) | Cite: | Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell, 187, 2024
|
|
5W23
 
 | Crystal Structure of RSV F in complex with 5C4 Fab | Descriptor: | 5C4 Fab heavy chain, 5C4 Fab light chain, Fusion glycoprotein F0, ... | Authors: | Battles, M.B, McLellan, J.S. | Deposit date: | 2017-06-05 | Release date: | 2017-12-06 | Last modified: | 2024-11-13 | Method: | X-RAY DIFFRACTION (3.4 Å) | Cite: | Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. Nat Commun, 8, 2017
|
|
5W24
 
 | Crystal Structure of 5C4 Fab | Descriptor: | (R,R)-2,3-BUTANEDIOL, 5C4 Fab Heavy Chain, 5C4 Fab Light Chain | Authors: | Battles, M.B, McLellan, J.S, Taher, N.M. | Deposit date: | 2017-06-05 | Release date: | 2017-12-06 | Last modified: | 2024-11-20 | Method: | X-RAY DIFFRACTION (1.5 Å) | Cite: | Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. Nat Commun, 8, 2017
|
|
5XSG
 
 | Ultrahigh resolution structure of FUS (37-42) SYSGYS determined by MicroED | Descriptor: | RNA-binding protein FUS | Authors: | Luo, F, Gui, X, Zhou, H, Li, D, Li, X, Liu, C. | Deposit date: | 2017-06-14 | Release date: | 2018-04-04 | Last modified: | 2024-03-27 | Method: | ELECTRON CRYSTALLOGRAPHY (0.73 Å) | Cite: | Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. Nat. Struct. Mol. Biol., 25, 2018
|
|
3OW9
 
 | |
2D5A
 
 | |
2D59
 
 | |
3Q2X
 
 | |
3PZZ
 
 | |
6V55
 
 | Full extracellular region of zebrafish Gpr126/Adgrg6 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Adhesion G-protein coupled receptor G6, CALCIUM ION | Authors: | Leon, K, Arac, D. | Deposit date: | 2019-12-03 | Release date: | 2020-01-15 | Last modified: | 2024-10-09 | Method: | X-RAY DIFFRACTION (2.38 Å) | Cite: | Structural basis for adhesion G protein-coupled receptor Gpr126 function. Nat Commun, 11, 2020
|
|
8D36
 
 | |
8D6Z
 
 | Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV91-27 | Descriptor: | Neutralizing antibody COV91-27 heavy chain, Neutralizing antibody COV91-27 light chain, Spike protein S2 fusion peptide | Authors: | Lee, C.C.D, Lin, T.H, Yuan, M, Wilson, I.A. | Deposit date: | 2022-06-06 | Release date: | 2022-07-27 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (2.3 Å) | Cite: | Broadly neutralizing antibodies target the coronavirus fusion peptide. Science, 377, 2022
|
|
5W5D
 
 | |
5W5C
 
 | |
5JYY
 
 | Structure-based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-resistant Influenza Viruses | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-7-O-[(2-methoxyethyl)carbamoyl]-D-glycero-D-galacto-non-2-enon ic acid, CALCIUM ION, ... | Authors: | Fu, L, Wu, Y, Bi, Y, Zhang, S, Lv, X, Qi, J, Li, Y, Lu, X, Yan, J, Gao, G.F, Li, X. | Deposit date: | 2016-05-15 | Release date: | 2016-06-29 | Last modified: | 2024-11-06 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | Structure-Based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-Resistant Influenza Viruses J.Med.Chem., 59, 2016
|
|